Founded in Eatontown, New Jersey, Immunostics is dedicated to providing advanced diagnostic solutions that enhance personalized patient care. The company's core mission is to offer innovative and practical diagnostic tools that assist healthcare professionals in the accurate diagnosis of diseases. Immunostics' product portfolio includes analyzers, infectious disease tests like the Swab-N-Go Home Test for COVID-19, and fecal occult blood tests such as hema-screen SPECIFIC GOLD. Their market focus spans across the healthcare continuum, aiming to deliver vital information for better patient outcomes.
Notable figures affiliated with Immunostics include key healthcare professionals and investors who have supported the company's growth and innovation. Among its key achievements, Immunostics has successfully developed a range of diagnostic products that are widely used in medical practices, contributing to more effective disease management and personalized treatment plans. The overall impact of Immunostics lies in its commitment to improving diagnostic accuracy and patient care, making significant strides in the healthcare diagnostics industry.